JFS Wealth Advisors, LLC
- SEC CIK
- 0001568068
- Latest filing
- Jul 10, 2026
BCRX holding history
Biocryst Pharmaceuticals Inc in every 13F filed by JFS Wealth Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BCRX overviewAll 13F holders of BCRXFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −40−100.0% | Sold out | Holders |
| Q1 2024 | 40 | $204 | <0.1% | +5+14.3% | Added | Holders |
| Q4 2023 | 35 | $210 | <0.1% | −33−48.5% | Reduced | Holders |
| Q3 2023 | 68 | $482 | <0.1% | +15+28.3% | Added | Holders |
| Q2 2023 | 53 | $374 | <0.1% | +29+120.8% | Added | Holders |
| Q1 2023 | 24 | $201 | <0.1% | −34−58.6% | Reduced | Holders |
| Q4 2022 | 58 | $666 | <0.1% | −3−4.9% | Reduced | Holders |
| Q3 2022 | 61 | $1.00K | <0.1% | +32+110.3% | Added | Holders |
| Q2 2022 | 29 | $0 | 0.0% | −14−32.6% | Reduced | Holders |
| Q1 2022 | 43 | $1.00K | <0.1% | +31+258.3% | Added | Holders |
| Q4 2021 | 12 | $0 | 0.0% | +12 | New | Holders |